- Drug Manufacturers - General
- Healthcare
Eli Lilly and Company
LLY · US ·
NYSE
908.05
USD
+23.67
(2.61%)
-
8.15
EPS
-
111.42
P/E
-
863B
MARKET CAP
-
0.54%
DIV YIELD
EPS Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 8.96 | 16.2 | 23.9 | 30.9 | 33 | 38.4 | 33.81% |
| Avg. Estimate | 8.15 | 13.8 | 19.9 | 25.5 | 30 | 35 | 33.81% |
| Low Estimate | 7.66 | 13.1 | 16.6 | 19.6 | 28.2 | 32.9 | 33.81% |
| No. Of Analysts | 9 | 12 | 14 | 10 | 4 | 5 |
Revenue Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 39.2B | 43.5B | 60.5B | 70.7B | 76.7B | 86B | 17.02% |
| Avg. Estimate | 38.9B | 43.1B | 55.6B | 65.8B | 71.3B | 80B | 15.50% |
| Low Estimate | 38.7B | 42.7B | 53B | 62.7B | 68B | 76.3B | 14.55% |
| No. Of Analysts | 19 | 14 | 19 | 23 | 19 | 13 |
Net Income Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 8.81B | 14.6B | 21.6B | 27.9B | 29.8B | 34.7B | 31.54% |
| Avg. Estimate | 7.34B | 12.5B | 18.2B | 23.2B | 27.1B | 31.6B | 33.89% |
| Low Estimate | 5.87B | 11.9B | 15B | 17.7B | 25.5B | 29.7B | 38.27% |
| No. Of Analysts | 19 | 14 | 19 | 23 | 19 | 13 |